Tag Archives: Coronavirus insights

Should people who have recently had COVID be vaccinated?

Matt Webster, Anglia Ruskin University A recent report from Public Health England showed that 83% of people who had had COVID were protected from reinfection five months later. Given that 3.7 million people in the UK have had COVID, should those with antibodies be at the back of the vaccine queue? With the current high death rate, rising case numbers, …

Read More »

COVID-19 vaccines: how and when will lower-income countries get access?

Rory Horner, University of Manchester COVID-19 vaccination programmes are gathering pace in high-income countries, but for much of the world, the future looks bleaker. Although a number of middle-income countries have started rolling out vaccines, widespread vaccination could still be years away. The first two COVID-19 vaccines authorised in Europe and the United States – made by Pfizer/BioNTech and Moderna …

Read More »

Coronavirus: why combining the Oxford vaccine with Russia’s Sputnik V vaccine could make it more effective

Jim Barber/Shutterstock Jameel Inal, University of Hertfordshire When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of the vaccine at stopping people developing symptomatic COVID-19, two weeks after the second dose, was 70%. But this wasn’t the whole picture. This figure was based on averaging the results from two groups. …

Read More »

Joggers and cyclists should wear masks – here’s why

Tom Wang/Shutterstock Trish Greenhalgh, University of Oxford England is deep into its third lockdown, yet the daily tally of new COVID cases and deaths remains sickeningly high. As Chris Whitty, the country’s chief medical officer, said recently, more needs to be done to bring the pandemic under control. Masks, which when worn correctly are highly effective in reducing transmission, are …

Read More »

Fake news: bold visual warnings needed to stop people clicking – new research

Shutterstock/dencg Fiona Carroll, Cardiff Metropolitan University A senior doctor in charge of the NHS anti-disinformation campaign has said that language and cultural barriers could be causing people from ethnic minorities to reject the COVID-19 vaccine. Dr Harpreet Sood told the BBC it was “a big concern” and officials were working hard to reach different groups “to correct so much fake …

Read More »

Oxford scientists: how we developed our COVID-19 vaccine in record time

University of Oxford Tonia Thomas, University of Oxford and Rachel Colin-Jones, University of Oxford The pandemic is only a year old, but we already have multiple vaccines available to fight COVID-19 – including the vaccine developed by the team we’re part of at the University of Oxford. With our partner AstraZeneca, we have submitted both interim efficacy data and safety …

Read More »

Vaccines alone aren’t enough to eradicate a virus – lessons from history

Dryvax, smallpox vaccine with bifurcated needle. James Gathany Content Providers/CDC Public Health Image Library Caitjan Gainty, King’s College London and Agnes Arnold-Forster, University of Bristol Smallpox killed countless millions – 300 million people in the 20th century alone – before it was finally declared eradicated on May 8 1980. It was a momentous day, marking what the current director general …

Read More »

Long COVID: who is at risk?

fizkes/Shutterstock Frances Williams, King’s College London For most people, infection with SARS-CoV-2 – the virus that causes COVID-19 – leads to mild, short-term symptoms, acute respiratory illness, or possibly no symptoms at all. But some people have long-lasting symptoms after their infection – this has been dubbed “long COVID”. Scientists are still researching long COVID. It’s not well understood, though …

Read More »

Oxford vaccine approved – now, here are 10 reasons why you should get vaccinated

Prostock-studio/Shutterstock Alessandro Siani, University of Portsmouth The Oxford-AstraZeneca COVID-19 vaccine has been authorised for use in the UK, meaning that millions more vaccine doses can now be delivered in the country. This will speed up progress towards achieving widespread immunity to the coronavirus. However, since the start of the pandemic – and particularly since vaccines for COVID-19 started being developed …

Read More »